Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
AK106-001616
DRUG
2 trials
Sponsors
Asahi Kasei Pharma Corporation
Conditions
Rheumatoid Arthritis
Phase 2
A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)
Completed
NCT00902369
Asahi Kasei Pharma Corporation
Rheumatoid Arthritis
Start: 2009-05-31
End: 2010-07-31
Target: 130
Updated: 2016-07-25
A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)
Completed
NCT01285752
Asahi Kasei Pharma Corporation
Rheumatoid Arthritis
Start: 2011-02-28
End: 2012-12-31
Target: 240
Updated: 2016-07-25
Related Papers
Evaluation of drug–drug interaction between the novel cPLA<sub>2</sub>inhibitor AK106-001616 and methotrexate in rheumatoid arthritis patients
Xenobiotica
2015-01-12
9 citations